Visual Impairment Following Stroke - The Impact on Quality of Life: A Systematic Review by Hepworth, Lauren & Rowe, Fiona
_____________________________________________________________________________________________________ 
 
*Corresponding author: E-mail: rowef@liverpool.ac.uk; 
 
 
 Ophthalmology Research: An International Journal  
5(2): 1-15, 2016, Article no.OR.23272             
 ISSN: 2321-7227 
 
SCIENCEDOMAIN international 
             www.sciencedomain.org 
 
 
Visual Impairment Following Stroke - The Impact on 
Quality of Life: A Systematic Review 
 
Lauren R. Hepworth1 and Fiona J. Rowe1* 
 
1Department of Health Services Research, University of Liverpool, Liverpool L69 3GB,  
United Kingdom. 
 
Authors’ contributions  
 
This work was carried out in collaboration between both authors. Author LRH ran searches, identified 
relevant studies, acted as first review author, extracted data, entered data, provided content expertise 
and co-wrote the final drafts. Author FJR led this review, provided methodological expertise, acted as 
a second review author. Both authors read and approved the final manuscript. 
 
Article Information 
 
DOI: 10.9734/OR/2016/23272 
Editor(s): 
(1) Ahmad M. Mansour, Department of Ophthalmology, American University of Beirut, Lebanon. 
Reviewers: 
(1) Sagili Chandrasekhara Reddy, National Defence University of Malaysia, Malaysia. 
(2) Elliot M. Kirstein, Western College of Optometry, USA. 
(3) Anonymous, University of Eastern Finland, Finland. 
(4) Asaad Ahmed Ghanem, Mansoura University, Egypt. 
Complete Peer review History: http://sciencedomain.org/review-history/12864 
 
 
 
Received 23rd November 2015  
Accepted 12th December 2015 
Published 1st January 2016 
 
 
ABSTRACT 
 
Background: The visual impairments caused by stroke have the potential to affect the ability of an 
individual to perform activities of daily living. An individual with visual impairment may also have 
reduced level of independence. The purpose of this review was to investigate the impact on quality 
of life from stroke related visual impairment, using subjective patient reported outcome measures.  
Methods: A systematic search of the literature was performed. The inclusion criteria required 
studies to have adult participants (aged 18 years or over) with a diagnosis of a visual impairment 
directly resulting from a stroke. Studies which included visual impairment as a result of other intra-
cranial aetiology, were included if over half of the participants were stroke survivors. Multiple 
scholarly online databases and registers of published, unpublished and ongoing trials were 
searched, in addition articles were hand searched. MESH terms and alternatives in relation to 
stroke and visual conditions were used. Study selection was performed by two authors 
independently. Data was extracted by one author and verified by a second. The quality of the 
evidence was assessed using a quality appraisal tool and reporting guidelines.  
Review Article 
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Results: This review included 11 studies which involved 5646 participants, the studies used a 
mixture of generic and vision-specific instruments. The seven instruments used by the included 
studies were the EQ-5D, LIFE-H, SF-36, NEI VFQ-25, VA LV VFQ-48, SRA-VFP and DLTV. 
Conclusion: A reduction in quality of life was reported by all studies in stroke survivors with visual 
impairment. Some studies used generic instruments, therefore making it difficult to extract the 
specific impact of the visual impairment as opposed to the other deficits caused by stroke. The 
majority of studies (8/11) primarily had participants with visual field loss. This skew towards visual 
field loss and no studies investigating the impact ocular motility prevented a comparison of the 
effects on quality of life due to different visual impairments caused by stroke. In order to fully 
understand the impact of visual impairment following stroke on quality of life, further studies need to 
use an appropriate vision-specific outcome measure and include all types of visual impairment 
which can result from a stroke.  
 
 
Keywords: Stroke; visual impairment; quality of life; impact; review. 
 
1. BACKGROUND 
 
Visual impairment as a result of a stroke takes 
many different guises across four main 
categories: Central vision loss, visual field loss, 
visual perception problems and ocular motility 
defects. All these impairments have the potential 
to affect the ability of an individual to perform 
activities of daily living (ADLs) for example 
mobility, social interaction and self-care. An 
individual with visual impairment may also have 
reduced level of independence. A combination of 
limitations has the potential to have an effect on 
an individual’s mood and motivation. These 
effects have been reported in populations with 
visual impairment [1-4].  
 
The World Health Organisation (WHO) defines 
health as “a state of complete physical, mental 
and social well-being and not merely the 
absence of disease or infirmity” [5]. The 
assessment of quality of life could be seen as a 
measurement of the subjective perceptions of an 
individual of how they are effected by their health 
state [1].  
 
The analysis of utility values of diabetic 
retinopathy and age-related macular 
degeneration revealed the impact on quality                   
of life was associated with the severity                           
of impairment rather than the cause [6]. 
However, it has also been shown that there is   
not a consistent trend between severity of 
symptoms and reduction in quality of life. The 
individuals with the most severe visual 
impairment may not report the poorest quality of 
life but those with a slight impairment may [7]. 
This highlights the importance of patient reported 
outcomes as part of clinical and research 
assessments.  
Stroke is a complex condition; an individual can 
be affected by a wide range of problems, for 
example physical disability (hemiplegia), 
communication disability (aphasia), feeding 
disability (dysphagia), cognitive disability, and 
visual impairment. It is important to establish the 
impact of the various components of stroke in 
order to evaluate interventions which are aimed 
at one of the specific disabilities [8].   
 
The aim of this review is to summarise the 
impact of stroke related visual impairment on 
quality of life. 
 
2. METHODS 
 
We conducted an integrative review, aiming to 
bring together all evidence relating to impact of 
stroke-related visual problems.  
 
2.1 Inclusion Criteria for Considering 
Studies for this Review 
 
2.1.1 Types of studies 
 
The following types of studies were included: 
randomised controlled trials, controlled trials, 
prospective and retrospective cohort studies and 
observational studies. Case reports were 
excluded. All languages were included and 
translations obtained when necessary.  
 
2.1.2 Types of participants 
 
We included studies of adult participants (aged 
18 years or over) diagnosed with a visual 
impairment as a direct result of a stroke. Studies 
which included mixed populations were included 
if over 50% of the participants had a diagnosis of 
stroke and data were available for this subgroup. 
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2.1.3 Types of outcome and data 
 
A formal quality of life assessment using a 
patient reported outcome measure (PROM). 
Studies which are assessing an intervention and 
have used a PROMs before and after, were 
included if the results prior to treatment were 
available for comparison to other studies.  
 
2.2 Search Methods for Identification of 
Studies  
 
We used systematic strategies to search key 
electronic databases and contacted known 
individuals conducting research in stroke and 
visual impairment. We searched Cochrane 
registers and electronic bibliographic databases 
(Appendix 1). In an effort to identify further 
published, unpublished and ongoing trials, we 
searched registers of ongoing trials, hand-
searched journals and conference transactions, 
performed citation tracking using Web of Science 
Cited Reference Search for all included studies, 
searched the reference lists of included trials and 
review articles about vision after acquired brain 
injury and contacted experts in the field 
(including authors of included trials, and 
excluded studies identified as possible 
preliminary or pilot work). Search terms included 
a comprehensive range of MeSH terms and 
alternatives in relation to stroke and visual 
conditions (Appendix 1). 
 
2.3 Selection of Studies 
 
The titles and abstracts identified from the search 
were independently screened by the two authors 
using the pre-stated inclusion criteria. The              
full papers of any studies considered               
potentially relevant were then considered and the 
selection criteria applied independently by the 
two authors.  
 
2.4 Data Extraction 
 
A pre-designed data extraction form was used 
which gathered information on sample size, 
study design, quality of life instrument used, 
visual conditions reported and population type. 
Data was extracted and documented by one 
researcher (LH) and verified by another (FR).  
 
2.5 Quality Assessment 
 
To assess the quality of the studies included in 
this review, an adapted version of a  checklist 
was used: The STROBE (Strengthening the 
Reporting of Observational Studies in 
Epidemiology) checklist [9,10]. The checklist    
was adapted as the original was designed                     
to assess the quality of reporting rather than                 
the potential for bias within a study. There                          
is currently no ‘gold standard’ quality assessment 
tool for observational studies [11]. The               
STROBE Statement covers 22 items covering 
introduction, method, results and discussion of 
observation studies (including cohort, case-
control and    cross-sectional studies) (Appendix 
2). The adapted version used in this review 
included 18 items, only the information which                  
is pertinent to quality appraisal of the studies        
was included. The items exclude which were                 
not considered relevant information, such as                 
the title, abstract, background, setting and 
funding.   
 
3. RESULTS AND DISCUSSION 
 
3.1 Results of the Search 
 
The search results are outlined in Fig. 1. Eleven 
studies (5646 participants) were included. Of the 
11 included studies, ten were prospective 
observational studies and one was a 
retrospective analyses. Seven different 
questionnaires were used in the included studies 
to report quality of life in stroke survivors with 
visual impairment.  
 
3.2 Quality of the Evidence 
 
Two of the eleven papers reported 100% of the 
items requested by the STROBE checklist [12]. 
Eight of the eleven papers reported 90% or more 
of the requested items, ten of the eleven papers 
reported 75% or more. All eleven papers 
reported 73% or more. The majority of papers 
(81%) reported limitations of their studies. 
Results from all papers were reported and the 
individual results for each paper are outlined in 
Table 1.  
 
3.3 Quality of Life Assessment for Stroke 
Survivors with Visual Impairment  
 
Eight studies investigating quality of life following 
stroke were focused on patients with visual field 
loss [12-19]. Homonymous hemianopia is the 
most common type of visual field loss following 
stroke. Other types of defect are possible 
including homonymous quadrantanopia, general 
constriction and scotomas [19]. Of the remaining 
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studies, Ali et al. [20] and Rowe et al. [21] 
address a combination of visual impairments 
following stroke while Beaudoin et al. [22] 
focused on visual perception problems.  
The included studies used both generic health-
related instruments and/or vision specific 
instruments which were administered to stroke 
survivors. 
 
 
 
Fig. 1. Flowchart of the pathway for inclusion of articles 
 
Full-text articles retrieved 
and assessed for 
eligibility  
n = 276 
Excluded n = 21,914 
Not relevant to the review 
Excluded n = 148 (Table 3) 
Not relevant n=30 
Review article n=30 
General population n=20 
Case study or small case 
series n=14 
<50% stroke diagnosis 
n=26 
Other non-empirical  
articles n=7 
Visual defects not  
discussed n= 4 
Abstract only n=3 
Insufficient information 
n=7 
Included in Cochrane 
Systematic review n=5 
Duplicate n=2 
 
 
Articles related to visual 
problems following stroke 
n = 128 
Studies identified from 
searching reference lists 
n = 31 
Titles identified through 
database searching  
n = 109,196 
Titles and abstracts 
screened  
n = 22,159 
Articles meeting inclusion 
criteria relating to impact  
n = 11 
Excluded n = 87,037 
Duplicates 
Case studies 
Editorials 
Letters 
Not Relevant 
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3.3.1 Generic Health-related Instruments 
 
The European Quality of Life Score (EQ-5D), the 
Medical-Outcome-Study Short-Form-36 Health 
Survey (SF-36) and the Assessment of Life 
Habits (LIFE-H) have been used to assess 
quality of life in individuals with visual impairment 
post-stroke. More details about these 
instruments can be viewed in Table 2. They are 
generic health-related instruments and are not 
vision specific. Generic instruments include items 
which are relevant to broad definition of health 
‘physical, mental and social well-being’ (WHO, 
1946). This allows comparisons to be made not 
only within a disease group but across difference 
disease groups; for example the EQ-5D is 
currently used in the NHS PROMs programme 
before and after four common surgeries (hip 
replacement, knee replacement, hernia repair 
and varicose vein surgery) [23]. However, they 
may not be sensitive to specific symptoms 
caused by visual impairment. 
 
The EQ-5D was reported to show that 
participants (n=3,859) with visual impairment 
following stroke had a poorer quality of life at 
baseline assessment after adjustment for age, 
thrombolysis treatment, other stroke non-visual 
related impairment and other medical conditions 
[20]. Visual impairment was assessed by using 
the National Institute of Health Stroke Scale 
(NIHSS), which only tests for homonymous 
visual field loss and horizontal gaze defects. 
Therefore, it misses many other forms of visual 
impairment thus, it is not possible for this study to 
give an overview of the impact of visual 
impairment following stroke. It reported that 
participants with conjugate deviations had 
reduced scores in all domains with the exception 
of anxiety/depression. Participants with 
hemianopia were reported to have reduced 
scores in self-care and usual activities. If the 
visual impairment was persistent to 90 days post-
stroke onset, those participants had poorer 
outcomes in all domains for participants with 
hemianopia and four out of five for participants 
with gaze palsies with the exception of pain and 
anxiety/depression [20].  
 
The LIFE-H reported the participants’ (n=93) 
quality of life to be persistently reduced in the 
presence of perceptual difficulties post-stroke 
compared to a group (n=96) without visuo-
perceptual deficits [22]. This difference was still 
present when controlling for the use of a walking 
aid and previous stroke events. The greatest 
difference was in socialisation rather than 
activities of daily living. This was shown at all 
three time points (n=57) of 18-24 days following 
discharge (baseline), then at three months and 
six months following baseline [22].  
 
The domains relating to employment and 
education were not included as part of this study, 
however, with the increasing number stroke 
survivors of working age, these areas are critical 
to examining how a visual defect affects all areas 
of life.   
 
The SF-36 has been used by three studies in 
conjunction with the NEI-VFQ and compared 
against healthy controls [12,16,17]. In each study 
stroke survivors with visual field defects were 
reported to have reduced scores in seven out of 
eight subscales (the exception being role 
limitation due to emotional problems). 
Participants with visual field defects were also 
reported to score better than general stroke 
survivors one month post-stroke without visual 
field defects [16]. However, when compared to 
general stroke survivors six months post-stroke 
without visual field defects, the participants with 
visual field defects had a reduced health-related 
quality of life [12,16]. When the composite scores 
of participants were compared with stroke 
survivors with different lesion ages (3, 6 and 12 
months post-stroke onset), those with visual field 
defects scored better in the physical composite 
score and worse in the mental composite score 
[12]. Individuals with visual field defects in 
combination with reduced visual acuity are 
reported to have a further reduction of scores 
across four sub-scales: physical functioning, 
vitality, social functioning and emotional well-
being [12]. The comparison groups used by 
these studies were from previously published 
data and therefore were not matched.  
 
3.3.2 Vision-specific instruments 
 
The National Eye Institute Visual Function 
Questionnaire (NEI VFQ-25), the Veterans Low 
Vision Visual Function Questionnaire (VA LV 
VFQ-48), the Self-Reported Assessment of 
Functional Visual Performance (SRAFVP) and 
the Daily Living Tasks Dependent on Vision 
(DLTV) have been used to assess quality of life 
in individuals with visual impairment post-stroke. 
More details about these instruments can be 
viewed in Table 2. Vision-specific instruments 
come under the wider disease-specific 
instruments umbrella and are tailored to assess 
quality of life in individuals with visual 
impairment. They can be more clinically sensitive 
to changes in visual impairment than generic 
instruments [24]. 
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Table 1. Quality appraisal of papers using the adapted STROBE checklist 
 
 Intro Methods Results Discussion 
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Ali et al. 2013 [20] + + + + + - + - - ? ? + -  + + + + + + 
Beaudoin et al. 2013 [22] + + + + + + - + - + + + + + + + + + 
Chen et al. 2009 [15] + + + + + - - + + + + + + n/a + - + + 
Gall et al. 2008 [17] + + + + + + + + + + + + + + + + + + 
Gall et al. 2009 [16] + + + + + + + + + + + + + + + - + + 
Gall et al. 2010 [12] + + + + + + + + + + + + + n/a + + + + 
George et al. 2011 [14] + + + + + - - + + + + + + + + + + + 
Mennem et al. 2012 [13] + + + + + + - + + ? + + + n/a + + + + 
Papageorgiou et al. 2007 
[18] 
+ + + + + - - + + - + + + + + + + + 
Rowe et al. 2013 [19] + + + + + - + + + - + + + n/a + + + + 
Rowe et al. 2013 [21] + + + + + - + + + + + + + + + + + + 
 
= Not reported   = Unclear                = Reported ? + - 
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Table 2. Patient Reported Outcome Measures (PROMs) used with stroke survivors 
 
Questionnaire Type of instrument Overview References 
EQ-5D Generic 5-item instrument, comprising of 5 
dimensions: mobility, self-care, 
usual activities, pain/discomfort 
and anxiety/depression with an 
additional health analogue scale.  
Ali et al. 2013 [20] 
 
LIFE-H Generic 77-item instrument comprising of 
12 domains split equally between 
daily activities and social roles.  
Beaudoin et al. 
2013 [22] 
SF-36 Generic 36-item general health instrument 
consisting of 8 domains. Widely 
used in health research.  
Gall et al. 2010 
[12] 
NEI-VFQ Vision-specific 25-item short version instrument, 
composed of 11 vision-related 
subscales with an additional 
question for general health rating. 
Used to assess many different 
ocular conditions.  
Chen et al. 2009 
[15] 
Gall et al. 2008; 
2009; 2010 
[12,16,17] 
George et al. 
2011 [14] 
Papageorgiou et 
al. 2007 [18] 
SRA-FVP Vision-specific 38 item instrument covering a 
range of activities of daily living. 
Mennem et al. 
2012 [13] 
VA LV VFQ Vision-specific 48 item instrument, composed of 
five domains: visual ability, 
reading, mobility, visual motor and 
visual information. Originally 
developed and validated with 
patients with ophthalmic pathology 
such as glaucoma, macular 
degeneration and diabetic 
retinopathy 
Chen et al. 2009 
[15] 
George et al. 
2011 [14] 
DLTV Vision-specific 24-item instrument which are not 
categorised under named domains, 
but covers topics such as reading, 
mobility, self-care and recognition. 
Originally developed for individuals 
with macular degeneration. 
Rowe et al. 2013 
[19,21] 
 
The most commonly used instrument is the NEI 
VFQ-25, and it is regarded to have good 
sensitivity to changes in visual impairment [25]. 
Six studies using the NEI VFQ-25 concentrated 
on visual field loss post-stroke [12,14-18]. Five 
studies compared the scores from the NEI VFQ-
25 of individuals with visual field loss post stroke 
and a reference health population and reported a 
reduced quality of life for those with visual field 
loss [12,15-18]. Gall et al. [17] also compared the 
scores of individuals with visual field loss post-
stroke to individuals diagnosed with glaucoma 
and reported the former group to have a poorer 
quality of life.  
The studies reported reduction in several sub-
scales in addition to the composite score. The 
number of affected sub-scales varied from seven 
up to all 12 sub-scales. Five subscales in 
common were found to have a significant 
difference between individuals with visual field 
loss post-stroke and healthy individuals: General 
health, general vision, near activities, vision-
specific mental health, driving, and peripheral 
vision [12,15-18]. Chen et al. [15] performed a 
multivariate analysis, adjusting for visual acuity, 
reading ability, contrast sensitivity and any pre-
existing ocular conditions which changed the 
sub-scales and were deemed significantly 
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different between the hemianopia and control 
group. Considering that the study had a very 
small sample size (n=10), following the 
multivariate analysis both the NEI VFQ-25 and 
VA LVQ-48 had a decreased in the number of 
subscales which were significantly affected, to 
five and one respectively. The factors adjusted 
for would not all be considered confounding 
factors but instead could also be a result of 
stroke and hemianopia, for example reduced 
reading ability [21]. The results following this 
multivariate analysis should be viewed as an 
assessment of quality of life with an isolated 
factor of hemianopia rather than visual 
impairment following stroke.  
 
Five studies used a combination of instruments; 
two studies used the NEI-VFQ-25 in conjunction 
with the VA LV VFQ-48 [14,15]. A further three 
studies used the NEI-VFQ-25 in conjunction with 
the SF-36 [12,16,17].  
 
Two of the studies investigated the effect of 
varying degrees of visual field loss post-stroke 
[12,17]. They reported that those with a greater 
area of spared central visual field had a better 
scores in the composite  score and the following 
subscales: distance vision, social functioning and 
colour vision [12]. Individuals with a 
quadrantanopia had similar scores to individuals 
diagnosed with glaucoma, therefore, were less 
affected than those with hemianopia [17].  
 
Several visual conditions can co-exist post stroke 
and this has the potential to have a larger impact 
on quality of life [26]. The presence of visual 
neglect has been shown to have a negative 
effect on the general health and mental health 
domains of the NEI VFQ-25 [16]. However, in the 
majority of domains participants with combined 
neglect and visual field loss were reported to 
have better quality of life than those with visual 
field loss without neglect. An explanation for this 
may be that those with visual neglect are less 
aware of their defect than those with visual field 
loss alone [21].  
 
Two studies compared and reported the quality 
of life impact in individuals with visual field loss 
post-stroke with good visual acuity versus 
reduced visual acuity [12,16]. Individuals with 
reduced visual acuity in addition to visual field 
loss had lower scores (reduced quality of life) in 
the majority of domains with the exception of 
ocular pain, the following domains showed a 
significant reduction; general vision, near vision, 
distance vision, social functioning, mental health, 
role difficulties, and dependency  [12]. 
Furthermore, Gall et al. [16] reported a link 
between reduced scores for both reduced visual 
acuity and slower reading speeds. 
 
George et al. [14] reported correlations between 
the objective assessments of the Behaviour 
Inattention Test (BIT) and the Mayo-Portland 
Adaptability Inventory (MPAI) and the subjective 
NEI VFQ-25 in participants with homonymous 
hemianopia. The BIT demonstrated the 
participants did not have attention deficits and it 
correlated well with eight out of twelve domains 
of the NEI VFQ-25. The instrument had a good 
association with both the participation and 
ability/adjustment scales of the MPAI. The 
participants (n=24) involved in this study 
performed well on objective testing, however the 
details of the patient reported outcome were not 
discussed [14]. The raw composite score of the 
NEI VFQ-25 in this study are comparable with 
those reported by Chen et al. [15], Papageorgiou 
et al. [18] and Gall et al. [12,16,17], all of these 
studies investigated participants with 
homonymous hemianopia.  
 
The Veterans Low Vision Visual Function 
Questionnaire (VA LV VFQ-48) has been used 
by two studies investigating quality of life post-
stroke in individuals with homonymous 
hemianopia [14,15]. Chen et al. [15] reported that 
initially the scores showed that individuals with 
hemianopia (n=10) had more difficulty with visual 
ability, mobility and visual motor functioning 
when compared to healthy controls. The 
differences for the reading and visual information 
subscales were found to be much smaller. When 
visual acuity, contrast sensitivity and the 
presence of pre-existing ocular conditions                      
were controlled for, the only remaining   
significant difference was mobility. George et al. 
[14] reported the correlations between the 
objective assessments of the Behaviour 
Inattention Test (BIT) and the Mayo-Portland 
Adaptability Inventory (MPAI) and the subjective 
VA LV VFQ-48 for participants with homonymous 
hemianopia without any attention deficits. The 
BIT correlated well with four out of five domains 
of the VA LV VFQ-48. The instrument had a 
good association with both the participation and 
ability/adjustment scales of the MPAI [14]. The 
raw scores for the VA LV VFQ-48 in this study 
are comparable with those reported by Chen et 
al. [15].  
 
The Self-Reported Assessment of Functional 
Visual Performance (SRAFVP) was used in a 
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preliminary prospective observational study with 
the aim of validating the instrument with 
individuals with homonymous hemianopia (n=30) 
[13]. They reported that functional mobility tasks 
were less difficult to perform than reading and 
eye-hand co-ordination tasks. Participants 
without macular sparing had significantly more 
problems with reading. This study reported good 
reliability and validity of the SRAFVP [13]. 
However, the study had several limitations 
including a small sample size, the majority of the 
sample were male (29:1) and individuals with 
inattention, aphasia and other ocular pathology 
were excluded.  
 
The Daily Living Tasks Dependent on Vision 
(DLTV) was used in a large cohort study 
involving individuals with a wide variety of 
different visual impairments following stroke [21]. 
Not all patients within the study completed the 
questionnaire as it was not a compulsory 
assessment. Two papers relating to visual 
symptoms and visual field loss report the findings 
of from the DLTV [21,27]. No significant 
difference in scores was found between those 
with visual impairment that reported symptoms 
and those that did not. Across all the symptom 
types and an asymptomatic group a wide range 
of scores was noted. Scores were reported to be 
reduced in individuals with visual impairment 
following stroke irrespective if any symptoms 
were reported [21]. Quality of life was shown to 
be reduced in individuals with multiple visual 
impairments when compared to individuals 
without visual impairment. The reduced score 
with multiple visual impairments was not 
significantly different to those diagnosed only 
with visual field loss [27].   
 
4. CONCLUSION 
 
Issues exist when extracting the specific impact 
of visual impairment following stroke from the 
impact of other sequelae of stroke, such as 
physical and cognitive impairments [8]. The 
wording of the NEI VFQ aids this task. All 
questions ask the participant specifically about 
the impact of vision. However, generic PROMs 
ask about the impact of their current health state 
on a particular aspect of health related quality of 
life. Consequently, the individual’s current health 
state could include any of the sequelae of stroke. 
This renders it impossible to establish how much 
of the impact on quality of life is as a result of 
visual impairment. Studies which adjust for 
multiple factors have shown that when adjusting 
for confounders, participants have a poorer 
quality of life. This is an important consideration 
for researchers when choosing PROMs for future 
studies in this area.  
 
Regardless of the instrument used, all studies 
similarly report that visual impairment following 
stroke results in a reduced quality of life. There 
are some differences in the areas of quality of life 
affected, relating in part to the range of 
instruments used and the sub-scales of these.  
 
Eight of the eleven included studies focused on 
visual field loss following stroke. One of the 
eleven was found to assess the impact of a 
specific ocular motility defect (horizontal gaze 
palsy) occurring following stroke. There is 
currently no literature reporting the impact of a 
wider range of ocular motility defects following 
stroke. Due to this skew towards visual field loss 
and lack of studies investigating the impact of 
ocular motility, it was not possible to compare the 
effects on quality of life due to different visual 
impairments caused by stroke.  
 
This review highlights the need for further 
research into the impact of visual impairment 
following stroke on quality of life using 
appropriate vision-specific outcome measures.  
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APPENDIX 
 
Appendix 1. Search options and search terms 
 
Databases: 
 
• Cochrane Stroke Group Trials Register 
• The Cochrane Eyes and Vision Group Trials Register 
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, latest 
issue); 
• MEDLINE (1950 to May 2014); 
• EMBASE (1980 to May 2014); 
• CINAHL (1982 to May 2014); 
• AMED (1985 to May 2014); 
• PsycINFO (1967 to May 2014); 
• Dissertations & Theses (PQDT) database (1861 to May 2014); 
• British Nursing Index (1985 to May 2014); 
• PsycBITE (Psychological Database for Brain Impairment Treatment Efficacy, 
www.psycbite.com). 
 
Registers: 
 
• ClinicalTrials.gov (http://clinicaltrials.gov/); 
• Current Controlled Trials (www.controlledtrials. com); 
• Trials Central (www.trialscentral.org); 
• Health Service Research Projects in Progress   
(wwwcf.nlm.nih.gov/hsr_project/home_proj.cfm); 
• National Eye Institute Clinical Studies Database 
(http://clinicalstudies.info.nih.gov/cgi/protinstitute.cgi?NEI.0.html) 
• British and Irish Orthoptic Journal, Australian Orthoptic Journal, and proceedings of the 
European Strabismological Association (ESA), International Strabismological Association 
(ISA), International Orthoptic Association (IOA) 
(http://pcwww.liv.ac.uk/~rowef/index_files/Page646.htm)  
• Proceedings of Association for Research in Vision and Ophthalmology (www.arvo.org); 
 
Terms: 
Cerebrovascular disorders/ 
Brain ischaemia/ 
Intracranial Arterial Disease 
Intracranial Arteriovenous 
Malformations/ 
“Intracranial Embolism and 
Thrombosis*/ 
Stroke/ 
 
Eye Movements/ 
Eye/ 
Eye Disease/ 
Visually Impaired Persons/ 
Vision Disorders/ 
Blindness/ 
Diplopia/ 
Vision, Binocular/ 
Vision, Monocular/ 
Visual Acuity/ 
Visual Fields/ 
Vision, Low/ 
Ocular Motility Disorders/ 
Blindness, Cortical/ 
Hemianopsia/ 
Abducens Nerve Diseases/ 
Abducens Nerve/ 
Oculomotor Nerve/ 
Trochlear Nerve/ 
Visual Perception/ 
Quality of Life 
Impact 
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Nystagmus 
strabismus 
smooth pursuits 
saccades 
depth perception 
stereopsis 
gaze disorder 
internuclear ophthalmoplegia 
Parinaud’s syndrome 
Weber’s syndrome 
skew deviation 
conjugate deviation 
oscillopsia 
visual tracking 
agnosia 
hallucinations 
OR                    OR OR 
AND 
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Appendix 2. STROBE statement [9,10] 
 
 
Item 
no 
Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the 
title or the abstract 
(b) Provide in the abstract an informative and balanced summary of 
what was done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation 
being reported 
Objectives 3 State specific objectives, including any pre-specified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including 
periods of recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and 
methods of selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and 
methods of case ascertainment and control selection. Give the 
rationale for the choice of cases and controls 
Cross-sectional study—Give the eligibility criteria, and the sources 
and methods of selection of participants 
(b) Cohort study—For matched studies, give matching criteria and 
number of exposed and unexposed 
Case-control study—For matched studies, give matching criteria 
and the number of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of 
methods of assessment (measurement). Describe comparability of 
assessment methods if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control 
for confounding 
(b) Describe any methods used to examine subgroups and 
interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was 
addressed 
Case-control study—If applicable, explain how matching of cases 
and controls was addressed 
Cross-sectional study—If applicable, describe analytical methods 
taking account of sampling strategy 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, confirmed 
eligible, included in the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
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Item 
no 
Recommendation 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders 
(b) Indicate number of participants with missing data for each 
variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and total 
amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary 
measures over time 
Case-control study—Report numbers in each exposure category, or 
summary measures of exposure 
Cross-sectional study—Report numbers of outcome events or 
summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-
adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and why 
they were included 
(b) Report category boundaries when continuous variables were 
categorized 
(c) If relevant, consider translating estimates of relative risk into 
absolute risk for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and magnitude 
of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from similar 
studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which the 
present article is based 
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